Identification, solubility enhancement and in vivo testing of a cyanide antidote candidate

Citations of this article
Mendeley users who have this article in their library.


Present studies focused on the in vitro testing, the solubility enhancement and the in vivo testing of methyl propyl trisulfide (MPTS), a newly identified sulfur donor to treat cyanide (CN) intoxication. To enhance the solubility of the lipophilic MPTS, various FDA approved co-solvents, surfactants and their combinations were applied. The order of MPTS solubility in the given co-solvents was found to be the following: ethanol >> PEG 200 ≈ PEG400 ≈ PEG300 > PG. The maximum solubility of MPTS was found at 90% ethanol of 177.11 ± 12.17 mg/ml. The order of MPTS solubility in different surfactants is Cremophor EL > Cremophor RH40 > polysorbate 80 > sodium deoxycholate > sodium cholate. The maximum solubility of 40.99 mg/ml was achieved with 20% Cremophor EL. A synergistic solubilizing effect encountered with the combination of 20% Cremophor EL + 75% ethanol lead to a 2900-fold increase (compared to water solubility) in solubility. The in vivo efficacy using intramuscular administration was determined on a therapeutic mice model and expressed as a ratio of CN LD50 with and without the test antidote(s) (APR). Intramuscular administration was shown to be effective and the therapeutic antidotal protection by MPTS alone and MPTS + thiosulfate (TS) was significantly higher than the present therapy of TS. © 2013 Elsevier B.V. All rights reserved.




Kovacs, K., Ancha, M., Jane, M., Lee, S., Angalakurthi, S., Negrito, M., … Petrikovics, I. (2013). Identification, solubility enhancement and in vivo testing of a cyanide antidote candidate. European Journal of Pharmaceutical Sciences, 49(3), 352–358.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free